Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Overall and gender-specific effects of intermittent preventive treatment of malaria with artemisinin-based combination therapies among schoolchildren in Mali: a three-group open label randomized controlled trial.
Maiga, H; OPONDO, C; CHICO, RM; Cohee, LM; Sagara, I; Djimde, A;
2022
American Journal of Tropical Medicine and Hygiene, (2022).107 4
Global estimates of pregnancies at risk of Plasmodium falciparum and P. Vivax infection in 2020 and changes in risk patterns since 2000.
GORE-LANGTON, GR; Cano, J; SIMPSON, H; Tatem, A; Tejedor‐Garavito, N; Wigley, AS; Carioli, A; Gething, PW; Weiss, DJ; CHANDRAMOHAN, D; Walker, PG T; CAIRNS, ME; CHICO, RM;
2022
(2022).107 No. 4 Supplement
Prevalence of sulfadoxine-pyrimethamine resistance markers of plasmodium falciparum among pregnant women in an area of high malaria transmission: Nchelenge, Zambia.
CHAPONDA, M; Mwanza, S; Hachizovu, S; Nambozi, M; Gwasupika, J; Chaponda, EN; CHANDRAMOHAN, D; CHICO, RM;
2022
American Journal of Tropical Medicine and Hygiene, (2022).107 4
Prevalence of sulfadoxine-pyrimethamine resistance markers of Plasmodium falciparum among pregnant women in an area of high malaria transmission: Nchelenge, Zambia.
Chaponda, M; Mwanza, S; Hachizovu, S; Nambozi, M; Gwasupika, J; Chaponda, EB; CHANDRAMOHAN, D; CHICO, RM;
2022
(2022).(4) 1422 107
Overall and gender-specific effects of intermittent preventive treatment of malaria with artemisinin-based combination therapies among schoolchildren in Mali: a three-group open label randomized controlled trial.
Maiga, H; OPONDO, C; CHICO, RM; Cohee, LM; Sagara, I; Djimde, A;
2022
(2022).(4) 0901 107
Global estimates of pregnancies at risk of Plasmodium falciparum and P. vivax infection in 2020 and changes in risk patterns since 2000.
GORE-LANGTON, G; Cano, J; SIMPSON, H; Tatem, A; Tejedor‐Garavito, N; Wigley, AS; Carioli, A; Gething, PW; Weiss, DJ; CHANDRAMOHAN, D; Walker, PG T; Cairns, ME; CHICO, RM;
2022
(2022).(4) 0928 107
Assessing seroprevalence and associated risk factors for multiple infectious diseases in Sabah, Malaysia using serological multiplex bead assays.
Chan, YL; PATTERSON, CL; Priest, JW; Stresman, G; William, T; Chua, TH; TETTEH, K; Lammie, P; DRAKELEY, C; Fornace, KM;
2022
Frontiers in public health, (2022).10, 10.3389/fpubh.2022.924316.
Linear and conformational determinants of visceral leishmaniasis diagnostic antigens rK28 and rK39.
SIMONSON, P; BHATTACHARYYA, T; El-Safi, S; MILES, MA;
2022
Parasites & vectors, (2022).15 1 10.1186/s13071-022-05495-1.
Safety and immunogenicity of an Ad26.ZEBOV booster dose in children previously vaccinated with the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen: an open-label, non-randomised, phase 2 trial.
MANNO, D; Bangura, A; Baiden, F; Kamara, AB; AYIEKO, P; Kallon, J; Foster, J; Conteh, M; CONNOR, NE; Koroma, B; Njie, Y; Borboh, P; Keshinro, B; Lawal, BJ; KROMA, MT; Otieno, GT; Deen, AT; CHOI, EM-L; BALAMI, AD; Gaddah, A; McLean, C; Luhn, K; Adetola, HH; Deen, GF; Samai, M; ... WATSON-JONES, D.
2022
The Lancet. Infectious diseases, (2022).23 3 10.1016/S1473-3099(22)00594-1.
G6PD testing and radical cure for Plasmodium vivax in Cambodia: A mixed methods implementation study.
Kheang, ST; Ridley, R; Ngeth, E; Ir, P; Ngor, P; Sovannaroth, S; Lek, D; Phon, S; Kak, N; YEUNG, S;
2022
PLoS One, (2022).17 10 10.1371/journal.pone.0275822.